18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma

Conclusion: 18F-FAPI-04 PET/CT performed better than 18F-FDG PET/CT in identification of primary tumors, LN metastasis, and DM and in TNM staging of PDAC.

Source: Journal of Nuclear Medicine - February 1, 2024 Category: Nuclear Medicine Authors: Li, X., Lu, N., Lin, L., Chen, Y., Yang, S., Wang, H., Liu, X., Wu, C., Xue, X., Su, X., Bai, X., Liang, T. Tags: Clinical Investigations Source Type: research